Chapter 24 : Host Genetic Factors in Resistance and Susceptibility to Malaria

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Host Genetic Factors in Resistance and Susceptibility to Malaria, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817558/9781555813307_Chap24-1.gif /docserver/preview/fulltext/10.1128/9781555817558/9781555813307_Chap24-2.gif


Well-controlled genetic studies are easier to conduct with mice than with humans, and it has long been known that certain strains of mice consistently show a greater degree of resistance to infection than other strains. It is clear that these differences are primarily genetic, rather than environmental or acquired. This chapter discusses specific genetic loci that have been identified as responsible for some of these differences. Genetic factors also appear to underlie some striking differences in resistance to malaria that have been observed between ethnic groups who live in the same area. The chapter deals with the growing list of genes that show some evidence of influencing resistance to malaria. Glycophorins A and B, encoded by the homologous genes GYPA and GYPB, are major sialoglycoproteins of the erythrocyte membrane, which carries the antigenic determinants for various blood groups. Hemoglobin S (HbS) homozygotes have sickle cell disease, a debilitating and often fatal disorder caused by the red blood cell deformities that result from this structural defect, particularly at low oxygen concentrations. The thalassemias are a group of genetic disorders due to defective production of α- or β- globin chains, arising from a diverse set of deletions and other disruptions of the globin gene clusters on chromosomes 11 and 16. Haptoglobin, encoded by the HP gene, is a protein found in plasma. Parasite sequestration in cerebral capillaries, a hallmark of human cerebral malaria, is notable by its absence in the ANKA (PBA) experimental model.

Citation: Kwiatkowski D, Luoni G. 2005. Host Genetic Factors in Resistance and Susceptibility to Malaria, p 462-479. In Sherman I (ed), Molecular Approaches to Malaria. ASM Press, Washington, DC. doi: 10.1128/9781555817558.ch24
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Abraham, L. J.,, and K. M. Kroeger. 1999. Impact of the −308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J. Leukoc. Biol. 66: 562 566.
2. Ackerman, H. C.,, G. Ribas,, M. Jallow,, R. Mott,, M. Neville,, F. Sisay-Joof,, M. Pinder,, R. D. Campbell,, and D. P. Kwiatkowski. 2003. Complex haplotypic structure of the central MHC region flanking TNF in a West African population. Genes Immun. 4: 476 486.
3. Agarwal, A.,, A. Guindo,, Y. Cissoko,, J. G. Taylor,, D. Coulibaly,, A. Kone,, K. Kayentao,, A. Djimde,, C. V. Plowe,, O. Doumbo,, T. E. Wellems,, and D. Diallo. 2000. Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S. Blood 96: 2358 2363.
4. Aidoo, M.,, P. D. McElroy,, M. S. Kolczak,, D. J. Terlouw,, F. O. ter Kuile,, B. Nahlen,, A. A. Lal,, and V. Udhayakumar. 2001. Tumor necrosis factor- alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX. Genet. Epidemiol. 21: 201 211.
5. Aitman, T. J.,, L.D. Cooper,, P. J. Norsworthy,, F.N. Wahid,, J. K. Gray,, B.R. Curtis,, P. M. McKeigue,, D. Kwiatkowski,, B. M. Greenwood,, R.W. Snow,, A.V. Hill,, and J. Scott. 2000. Malaria susceptibility and CD36 mutation. Nature 405: 1015 1016.
6. Allen, S. J.,, S. Bennett,, E. M. Riley,, P. A. Rowe,, P. H. Jakobsen,, A. O’Donnell,, and B. M. Greenwood. 1992. Morbidity from malaria and immune responses to defined Plasmodium falciparum antigens in children with sickle cell trait in The Gambia. Trans. R. Soc.Trop. Med. Hyg. 86: 494 498.
7. Allen, S. J.,, A. O’Donnell,, N. D. Alexander,, M. P. Alpers,, T. E. A. Peto,, J. B. Clegg,, and D. J. Weatherall. 1997. a1-Thalassemia protects children against disease caused by other infections as well as malaria. Proc. Natl.Acad. Sci.USA 94: 14736 14741.
8. Allen, S. J.,, A. O’Donnell,, N. D. Alexander,, C. S. Mgone,, T. E. Peto,, J. B. Clegg,, M. P. Alpers,, and D. J. Weatherall. 1999. Prevention of cerebral malaria in children in Papua New Guinea by southeast Asian ovalocytosis band 3. Am.J.Trop. Med. Hyg. 60: 1056 1060.
9. Allison, A. C. 1954. Protection afforded by sickle-cell trait against subtertian malareal infection. Br. Med. J. 4857: 290 294.
10. Amani, V.,, M. I. Boubou,, S. Pied,, M. Marussig,, D. Walliker,, D. Mazier,, and L. Renia. 1998. Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria. Infect. Immun. 66: 4093 4099.
11. Aucan, C.,, A. J. Walley,, B. M. Greenwood,, and A.V. Hill. 2002. Haptoglobin genotypes are not as- sociated with resistance to severe malaria in The Gambia. Trans. R. Soc.Trop. Med. Hyg. 96: 327 328.
12. Aucan, C.,, A. J. Walley,, B. J. Hennig,, J. Fitness,, A. Frodsham,, L. Zhang,, D. Kwiatkowski,, and A.V. Hill. 2003. Interferon-alpha receptor-1 (IFNAR1) variants are associated with protection against cerebral malaria in The Gambia. Genes Immun. 4: 275 282.
13. Bagot, S.,, S. Campino,, C. Penha-Goncalves,, S. Pied,, P. A. Cazenave,, and D. Holmberg. 2002a. Identification of two cerebral malaria resistance loci using an inbred wild-derived mouse strain. Proc. Natl.Acad. Sci. USA 99: 9919 9923.
Bagot, S.,, M. Idrissa Boubou,, S. Campino,, C. Behrschmidt,, O. Gorgette,, J. L. Guenet,, C. Penha-Goncalves,, D. Mazier,, S. Pied,, and P.A. Cazenave. 2002.b. Susceptibility to experimental cerebral malaria induced by Plasmodium berghei ANKA in inbred mouse strains recently derived from wild stock. Infect. Immun. 70: 2049 2056.
15. Baird, J. K. 1995. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol.Today 11: 105 111.
16. Baird, J. K.,, S. Masbar,, H. Basri,, S. Tirtokusumo,, B. Subianto,, and S. L. Hoffman. 1998. Agedependent susceptibility to severe disease with primary exposure to Plasmodium falciparum. J. Infect. Dis. 178: 592 595.
17. Barnwell, J.W.,, A. S. Asch,, R. L. Nachman,, M. Yamaya,, M. Aikawa,, and P. Ingravallo. 1989. A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. J. Clin. Investig. 84: 765 772.
18. Baum, J.,, R. H. Ward,, and D. J. Conway. 2002. Natural selection on the erythrocyte surface. Mol. Biol. Evol. 19: 223 229.
19. Bayley, J. P.,, T. H. Ottenhoff,, and C. L. Verweij. 2004. Is there a future for TNF promoter polymorphisms? Genes Immun. 5: 315 329.
20. Bellamy, R.,, D. Kwiatkowski,, and A.V. Hill. 1998a. Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population. Trans. R. Soc.Trop. Med. Hyg. 92: 312 316.
21. Bellamy, R.,, C. Ruwende,, K. P. McAdam,, M. Thursz,, M. Sumiya,, J. Summerfield,, S. C. Gilbert,, T. Corrah,, D. Kwiatkowski,, H.C. Whittle,, and A.V. Hill. 1998b. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans. QJM 91: 13 18.
22. Bennett, S.,, S. J. Allen,, O. Olerup,, D. J. Jackson,, J. G. Wheeler,, P.A. Rowe,, E. M. Riley,, and B. M. Greenwood. 1993. Human leucocyte antigen (HLA) and malaria morbidity in a Gambian community. Trans. R. Soc.Trop. Med. Hyg. 87: 286 287.
23. Berendt, A. R.,, D. L. Simmons,, J. Tansey,, C. I. Newbold,, and K. Marsh. 1989. Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 341: 57 59.
24. Burgner, D.,, S. Usen,, K. Rockett,, M. Jallow,, H. Ackerman,, A. Cervino,, M. Pinder,, and D. P. Kwiatkowski. 2003. Nucleotide and haplotypic diversity of the NOS2A promoter region and its relationship to cerebral malaria. Hum.Genet. 112: 379 386.
25. Burgner, D.,, W. Xu,, K. Rockett,, M. Gravenor,, I. G. Charles,, A.V. Hill,, and D. Kwiatkowski. 1998. Inducible nitric oxide synthase polymorphism and fatal cerebral malaria. Lancet 352: 1193 1194.
26. Burt, R. A.,, T. M. Baldwin,, V. M. Marshall,, and S. J. Foote. 1999. Temporal expression of an H2- linked locus in host response to mouse malaria. Immunogenetics 50: 278 285.
27. Burt, R. A.,, V. M. Marshall,, J. Wagglen,, F. R. Rodda,, D. Senyschen,, T. M. Baldwin,, L. A. Buckingham,, and S. J. Foote. 2002. Mice that are congenic for the char2 locus are susceptible to malaria. Infect. Immun. 70: 4750 4753.
28. Casals-Pascual, C.,, S. Allen,, A. Allen,, O. Kai,, B. Lowe,, A. Pain,, and D. J. Roberts. 2001. Short report:codon 125 polymorphism of CD31 and susceptibility to malaria. Am.J.Trop. Med.Hyg. 65: 736 737.
29. Cattani, J.A.,, F.D. Gibson,, M. P. Alpers,, and G.G. Crane. 1987. Hereditary ovalocytosis and reduced susceptibility to malaria in Papua New Guinea. Trans. R. Soc.Trop. Med. Hyg. 81: 705 709.
30. Chitnis, C. E.,, and L. H. Miller. 1994. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J. Exp. Med. 180: 497 506.
31. Chotivanich, K.,, R. Udomsangpetch,, K. Pattanapanyasat,, W. Chierakul,, J. Simpson,, S. Looareesuwan, and N.White. 2002. Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P falciparum malaria. Blood 100: 1172 1176.
32. Clark, I. A.,, and K. A. Rockett. 1996. Nitric oxide and parasitic disease. Adv. Parasitol. 37: 1 56.
33. Cockburn, I. A.,, M. J. Mackinnon,, A. O’Donnell,, S. J. Allen,, J. M. Moulds,, M. Baisor,, M. Bockarie,, J. C. Reeder,, and J. A. Rowe. 2004. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc. Natl. Acad Sci. USA 101: 272 277.
34. Cooke, G. S.,, C. Aucan,, A. J. Walley,, S. Segal,, B. M. Greenwood,, D. P. Kwiatkowski,, and A.V. Hill. 2003. Association of Fcγ receptor IIa (CD32) polymorphism with severe malaria in West Africa. Am. J.Trop. Med. Hyg. 69: 565 568.
35. Diallo, D.A.,, O. K. Doumbo,, A. Dicko,, A. Guindo,, D. Coulibaly,, K. Kayentao,, A.A. Djimde,, M.A. Thera,, R. M. Fairhurst,, C.V. Plowe,, and T. E. Wellems. 2004. A comparison of anemia in hemoglobin C and normal hemoglobin A children with Plasmodium falciparum malaria. Acta Trop. 90: 295 299.
36. Elagib, A. A.,, A. O. Kider,, B. Akerstrom,, and M. I. Elbashir. 1998. Association of the haptoglobin phenotype (1-1) with falciparum malaria in Sudan. Trans. R. Soc.Trop. Med. Hyg. 92: 309 311.
37. Engwerda, C. R.,, T. L. Mynott,, S. Sawhney,, J. B. De Souza,, Q. D. Bickle,, and P. M. Kaye. 2002. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha,is the principle mediator of murine cerebral malaria. J. Exp. Med. 195: 1371 1377.
38. Facer, C.A. 1983. Merozoites of P. falciparum require glycophorin for invasion into red cells. Bull. Soc. Pathol. Exot. Filiales 76: 463 469.
39. Fernandez-Reyes, D.,, A. G. Craig,, S. A. Kyes,, N. Peshu,, R.W. Snow,, A. R. Berendt,, K. Marsh,, and C. I. Newbold. 1997. A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum. Mol. Genet. 6: 1357 1360.
40. Flint, J.,, A.V. Hill,, D. K. Bowden,, S. J. Oppenheimer,, P. R. Sill,, S.W. Serjeantson,, J. Bana- Koiri,, K. Bhatia,, M. P. Alpers,, A. J. Boyce, et al. 1986. High frequencies of alpha-thalassaemia are the result of natural selection by malaria. Nature 321: 744 750.
41. Flori, L.,, S. Sawadogo,, C. Esnault,, N. F. Delahaye,, F. Fumoux,, and P. Rihet. 2003. Linkage of mild malaria to the major histocompatibility complex in families living in Burkina Faso. Hum. Mol. Genet. 12: 375 378.
42. Foo, L. C.,, V. Rekhraj,, G. L. Chiang,, and J.W. Mak. 1992. Ovalocytosis protects against severe malaria parasitemia in the Malayan aborigines. Am. J.Trop. Med. Hyg. 47: 271 275.
43. Foote, S. J.,, R.A. Burt,, T. M. Baldwin,, A. Presente,, A. W. Roberts,, Y. L. Laural,, A. M. Lew,, and V. M. Marshall. 1997. Mouse loci for malariainduced mortality and the control of parasitaemia. Nat. Genet. 17: 380 381.
44. Fortin, A.,, A. Belouchi,, M. F. Tam,, L. Cardon,, E. Skamene,, M. M. Stevenson,, and P. Gros. 1997. Genetic control of blood parasitaemia in mouse malaria maps to chromosome 8. Nat.Genet. 17: 382 383.
45. Fortin, A.,, L. R. Cardon,, M. Tam,, E. Skamene,, M. M. Stevenson,, and P. Gros. 2001. Identification of a new malaria susceptibility locus (Char4) in recombinant congenic strains of mice. Proc. Natl. Acad. Sci. USA 98: 10793 10798.
46. Ganczakowski, M.,, M. Town,, D. K. Bowden,, T. J. Vulliamy,, A. Kaneko,, J. B. Clegg,, D. J. Weatherall,, and L. Luzzatto. 1995. Multiple glucose 6- phosphate dehydrogenase-deficient variants correlate with malaria endemicity in the Vanuatu archipelago (southwestern Pacific). Am. J. Hum. Genet. 56: 294 301.
47. Garcia, A.,, M. Cot,, J. P. Chippaux,, S. Ranque,, J. Feingold,, F. Demenais,, and L. Abel. 1998a. Genetic control of blood infection levels in human malaria: evidence for a complex genetic model. Am. J.Trop. Med. Hyg. 58: 480 488.
48. Garcia, A.,, S. Marquet,, B. Bucheton,, D. Hillaire,, M. Cot,, N. Fievet,, A. J. Dessein,, and L. Abel. 1998b. Linkage analysis of blood Plasmodium falciparum levels: interest of the 5q31-q33 chromosome region. Am. J.Trop. Med. Hyg. 58: 705 709.
49. Genton, B.,, F. al-Yaman,, C. S. Mgone,, N. Alexander,, M.M. Paniu,, M. P. Alpers,, and D. Mokela. 1995. Ovalocytosis and cerebral malaria. Nature 378: 564 565.
50. Gilbert, S. C.,, M. Plebanski,, S. Gupta,, J. Morris,, M. Cox,, M. Aidoo,, D. Kwiatkowski,, B. M. Greenwood,, H.C. Whittle,, and A.V. Hill. 1998. Association of malaria parasite population structure, HLA, and immunological antagonism. Science 279: 1173 1177.
51. Gilles, H. M.,, K. A. Fletcher,, R. G. Hendrickse,, R. Lindner,, S. Reddy,, and N. Allan. 1967. Glucose- 6-phosphate-dehydrogenase deficiency, sickling, and malaria in African children in south western Nigeria. Lancet 1: 138 140.
52. Grau, G. E.,, L. F. Fajardo,, P. F. Piguet,, B. Allet,, P. H. Lambert,, and P. Vassalli. 1987a. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237: 1210 1212.
53. Grau, G. E.,, D. Gretener,, and P. H. Lambert. 1987b. Prevention of murine cerebral malaria by low-dose cyclosporin A. Immunology 61: 521 525.
54. Grau, G. E.,, H. Heremans,, P. F. Piguet,, P. Pointaire,, P. H. Lambert,, A. Billiau,, and P. Vassalli. 1989. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc. Natl.Acad. Sci. USA 86: 5572 5574.
55. Greenberg, J.,, and L. P. Kendrick. 1959. Resistance to malaria in hybrids between Swiss and certain other strains of mice. J. Parasitol. 45: 263 267.
56. Greenberg, J.,, E. M. Nadel,, and G. R. Coatney. 1954. Differences in survival of several inbred strains of mice and their hybrids infected with Plasmodium berghei. J. Infect. Dis. 95: 114 116.
57. Hill, A.V.,, C. E. Allsopp,, D. Kwiatkowski,, N. M. Anstey,, P. Twumasi,, P. A. Rowe,, S. Bennett,, D. Brewster,, A. J. McMichael,, and B. M. Greenwood. 1991. Common west African HLA antigens are associated with protection from severe malaria. Nature 352: 595 600
58. Hill, A.V.,, J. Elvin,, A.C. Willis,, M. Aidoo,, C. E. Allsopp,, F. M. Gotch,, X. M. Gao,, M. Takiguchi,, B. M. Greenwood,, A. R. Townsend, et al. 1992. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360: 434 439.
59. Hobbs, M. R.,, V. Udhayakumar,, M. C. Levesque,, J. Booth,, J. M. Roberts,, A.N. Tkachuk,, A. Pole,, H. Coon,, S. Kariuki,, B. L. Nahlen,, E. D. Mwaikambo,, A. L. Lal,, D. L. Granger,, N. M. Anstey,, and J. B. Weinberg. 2002. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet 360: 1468 1475.
60. Hunt, N. H.,, C. Driussi,, and L. Sai-Kiang. 2001. Haptoglobin and malaria. Redox Rep. 6: 389 392.
61. Hunt, N. H.,, N. Manduci,, and C. M. Thumwood. 1993. Amelioration of murine cerebral malaria by dietary restriction. Parasitology 107: 471 476.
62. Jayawardena, A. N.,, R. Mogil,, D. B. Murphy,, D. Burger,, and R. K. Gershon. 1983. Enhanced expression of H-2K and H-2D antigens on reticulocytes infected with Plasmodium yoelii. Nature 302: 623 626.
63. Jepson, A.,, F. Sisay-Joof,, W. Banya,, M. Hassan- King,, A. Frodsham,, S. Bennett,, A.V. Hill,, and H. Whittle. 1997. Genetic linkage of mild malaria to the major histocompatibility complex in Gambian children: study of affected sibling pairs. BMJ 315: 96 97.
64. Jepson, A.P.,, W.A. Banya,, F. Sisay-Joof,, M. Hassan- King,, S. Bennett,, and H. C. Whittle. 1995. Genetic regulation of fever in Plasmodium falciparum malaria in Gambian twin children. J. Infect. Dis. 172: 316 319.
65. Juliger, S.,, M. Bongartz,, A. J. Luty,, P.G. Kremsner,, and J. F. Kun. 2003. Functional analysis of a promoter variant of the gene encoding the interferongamma receptor chain I. Immunogenetics 54: 675 680.
66. Kikuchi, M.,, S. Looareesuwan,, R. Ubalee,, O. Tasanor,, F. Suzuki,, Y. Wattanagoon,, K. Na- Bangchang,, A. Kimura,, M. Aikawa,, and K. Hirayama. 2001. Association of adhesion molecule PECAM-1/CD31 polymorphism with susceptibility to cerebral malaria in Thais. Parasitol. Int. 50: 235 239.
67. Kitchen, S. F., 1949. Symptomatology: general considerations, p. 966 994. In M.F. Boyd (ed.), Malariology. W. B. Saunders, Philadelphia, Pa.
68. Knight, J. C.,, B. J. Keating,, K. A. Rockett,, and D. P. Kwiatkowski. 2003. In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat. Genet. 33: 469 475.
69. Knight, J. C.,, I. Udalova,, A.V. Hill,, B. M. Greenwood,, N. Peshu,, K. Marsh,, and D. Kwiatkowski. 1999. A polymorphism that affects OCT- 1 binding to the TNF promoter region is associated with severe malaria. Nat. Genet. 22: 145 150.
70. Koch, O.,, A. Awomoyi,, S. Usen,, M. Jallow,, A. Richardson,, J. Hull,, M. Pinder,, M. Newport,, and D. Kwiatkowski. 2002. IFNGR1 gene promoter polymorphisms and susceptibility to cerebral malaria. J. Infect. Dis. 185: 1684 1687.
71. Kremsner, P. G.,, H. Grundmann,, S. Neifer,, K. Sliwa,, G. Sahlmuller,, B. Hegenscheid,, and U. Bienzle. 1991. Pentoxifylline prevents murine cerebral malaria. J. Infect. Dis. 164: 605 608.
72. Kun, J. F.,, J. Klabunde,, B. Lell,, D. Luckner,, M. Alpers,, J. May,, C. Meyer,, and P. G. Kremsner. 1999. Association of the ICAM-1Kilifi mutation with protection against severe malaria in Lambarene, Gabon. Am. J.Trop. Med. Hyg. 61: 776 779.
73. Kun, J. F.,, B. Mordmuller,, B. Lell,, L. G. Lehman,, D. Luckner,, and P. G. Kremsner. 1998. Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 351: 265 266.
74. Kun, J. F.,, B. Mordmuller,, D. J. Perkins,, J. May,, O. Mercereau-Puijalon,, M. Alpers,, J. B. Weinberg,, and P. G. Kremsner. 2001. Nitric oxide synthase 2(Lambarene) (G-954C), increased nitric oxide production, and protection against malaria. J. Infect. Dis. 184: 330 336.
75. Kwiatkowski, D.,, and P. Perlmann,. 1999. Inflammatory processes in the pathogenesis of malaria, p. 329 362. In M. Wahlgen, and P. Perlmann (ed.), Malaria: Molecular and Clinical Aspects. Harwood Academic Publishers, The Netherlands.
76. Levesque, M.C.,, M. R. Hobbs,, N. M. Anstey,, T.N. Vaughn,, J.A. Chancellor,, A. Pole,, D. J. Perkins,, M.A. Misukonis,, S. J. Chanock,, D. L. Granger,, and J. B. Weinberg. 1999. Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria. J. Infect. Dis. 180: 1994 2002.
77. Luoni, G.,, F. Verra,, B. Arca,, B. S. Sirima,, M. Troye- Blomberg,, M. Coluzzi,, D. Kwiatkowski,, and D. Modiano. 2001. Antimalarial antibody levels and IL4 polymorphism in the Fulani of West Africa. Genes Immun. 2: 411 414.
78. Luty, A. J.,, J. F. Kun,, and P. G. Kremsner. 1998. Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria. J. Infect. Dis. 178: 1221 1224.
79. Luzzatto, L.,, F.A. Usanga,, and S. Reddy. 1969. Glucose- 6-phosphate dehydrogenase deficient red cells: resistance to infection by malarial parasites. Science 164: 839 842.
80. Maier, A. G.,, M.T. Duraisingh,, J. C. Reeder,, S. S. Patel,, J. W. Kazura,, P. A. Zimmerman,, and A. F. Cowman. 2003. Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat. Med. 9: 87 92.
81. Mayor, A.,, N. Bir,, R. Sawhney,, S. Singh,, P. Pattnaik,, S. K. Singh,, A. Sharma,, and C. E. Chitnis. 2005. Receptor-binding residues lie in central regions of Duffy-binding-like domains involved in red cell invasion and cytoadherence by malaria parasites. Blood 105: 2557 2563.
82. McGuire, W.,, A. V. Hill,, C. E. Allsopp,, B. M. Greenwood,, and D. Kwiatkowski. 1994. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371: 508 510.
83. McGuire, W.,, J.C. Knight,, A.V. Hill,, C. E. Allsopp,, B. M. Greenwood,, and D. Kwiatkowski. 1999. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J. Infect. Dis. 179: 287 290.
84. Meyer, C. G.,, J. May,, A. J. Luty,, B. Lell,, and P. G. Kremsner. 2002. TNFα-308A associated with shorter intervals of Plasmodium falciparum reinfections. Tissue Antigens 59: 287 292.
85. Miller, L. H.,, S. J. Mason,, D. F. Clyde,, and M. H. McGinniss. 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 295: 302 304.
86. Min-Oo, G.,, A. Fortin,, M. F. Tam,, P. Gros,, and M. M. Stevenson. 2004. Phenotypic expression of pyruvate kinase deficiency and protection against malaria in a mouse model. Genes Immun. 5: 168 175.
87. Min-Oo, G.,, A. Fortin,, M. F. Tam,, A. Nantel,, M. M. Stevenson,, and P. Gros. 2003. Pyruvate kinase deficiency in mice protects against malaria. Nat. Genet. 35: 357 362.
88. Mockenhaupt, F. P.,, S. Ehrhardt,, S. Gellert,, R. N. Otchwemah,, E. Dietz,, S. D. Anemana,, and V. Bienzle. 2004. Alpha(+-thalassemia protects African children from severe malaria. Blood 104: 2003 2006.
89. Modiano, D.,, A. Chiucchiuini,, V. Petrarca,, B. S. Sirima,, G. Luoni,, H. Perlmann,, F. Esposito,, and M. Coluzzi. 1998. Humoral response to Plasmodium falciparum Pf155/ring-infected erythrocyte surface antigen and Pf332 in three sympatric ethnic groups of Burkina Faso. Am. J. Trop. Med. Hyg. 58: 220 224.
90. Modiano, D.,, A. Chiucchiuini,, V. Petrarca,, B. S. Sirima,, G. Luoni,, M. A. Roggero,, G. Corradin,, M. Coluzzi,, and F. Esposito. 1999. Interethnic differences in the humoral response to non-repetitive regions of the Plasmodium falciparum circumsporozoite protein. Am.J.Trop. Med.Hyg. 61: 663 667.
91. Modiano, D.,, G. Luoni,, B. S. Sirima,, A. Lanfrancotti,, V. Petrarca,, F. Cruciani,, J. Simpore,, B. M. Ciminelli,, E. Foglietta,, P. Grisanti,, I. Bianco,, G. Modiano,, and M. Coluzzi. 2001a. The lower susceptibility to Plasmodium falciparum malaria of Fulani of Burkina Faso (west Africa) is associated with low frequencies of classic malaria-resistance genes. Trans. R. Soc.Trop. Med. Hyg. 95: 149 152.
92. Modiano, D.,, G. Luoni,, B. S. Sirima,, J. Simpore,, F. Verra,, A. Konate,, E. Rastrelli,, A. Olivieri,, C. Calissano,, G. M. Paganotti,, L. D’Urbano,, I. Sanou,, A. Sawadogo,, G. Modiano,, and M. Coluzzi. 2001b. Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature 414: 305 308.
93. Modiano, D.,, V. Petrarca,, B. S. Sirima,, I. Nebie,, D. Diallo,, F. Esposito,, and M. Coluzzi. 1996. Different response to Plasmodium falciparum malaria in West African sympatric ethnic groups. Proc. Natl. Acad. Sci. USA 93: 13206 13211.
94. Morahan, G.,, C. S. Boutlis,, D. Huang,, A. Pain,, J. R. Saunders,, M. R. Hobbs,, D. L. Granger,, J. B. Weinberg,, N. Peshu,, E. D. Mwaikambo,, K. Marsh,, D. J. Roberts,, and N. M. Anstey. 2002. A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production. Genes Immun. 3: 414 418.
95. Nadel, E.,, J. Greenberg,, G. E. Jay,, and G. R. Coatney. 1955. Backcross studies on the genetics of resistance to malaria in mice. Genetics 40: 620 626.
96. Nagayasu, E.,, M. Ito,, M. Akaki,, Y. Nakano,, M. Kimura,, S. Looareesuwan,, and M. Aikawa. 2001. CR1 density polymorphism on erythrocytes of falciparum malaria patients in Thailand. Am. J. Trop. Med. Hyg. 64: 1 5.
97. Nagayasu, E.,, K. Nagakura,, M. Akaki,, G. Tamiya,, S. Makino,, Y. Nakano,, M. Kimura,, and M. Aikawa. 2002. Association of a determinant on mouse chromosome 18 with experimental severe Plasmodium berghei malaria. Infect. Immun. 70: 512 516.
98. Neill, A. L.,, T. Chan-Ling,, and N. H. Hunt. 1993. Comparisons between microvascular changes in cerebral and non-cerebral malaria in mice, using the retinal whole-mount technique. Parasitology 107: 477 487.
99. Neill, A. L.,, and N. H. Hunt. 1992. Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice. Parasitology 105: 165 175.
100. Ohashi, J.,, I. Naka,, J. Patarapotikul,, H. Hananantachai,, G. Brittenham,, S. Looareesuwan,, A.G. Clark,, and K. Tokunaga. 2004. Extended linkage disequilibrium surrounding the hemoglobin E variant due to malarial selection. Am. J. Hum. Genet. 74: 1198 1208.
101. Ohno, T.,, and M. Nishimura. 2004. Detection of a new cerebral malaria susceptibility locus, using CBA mice. Immunogenetics 56: 675 678.
102. Omi, K.,, J. Ohashi,, J. Patarapotikul,, H. Hananantachai,, I. Naka,, S. Looareesuwan,, and K. Tokunaga. 2003. CD36 polymorphism is associated with protection from cerebral malaria. Am.J.Hum.Genet. 72: 364 374.
103. Omi, K.,, J. Ohashi,, J. Patarapotikul,, H. Hananantachai,, I. Naka,, S. Looareesuwan,, and K. Tokunaga. 2002. Fcγ receptor IIA and IIIB polymorphisms are associated with susceptibility to cerebral malaria. Parasitol. Int. 51: 361 366.
104. Orlandi, P.A.,, F.W. Klotz,, and J.D. Haynes. 1992. A malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum recognizes the terminal Neu5Ac((2-3)Gal- sequences of glycophorin A. J. Cell Biol. 116: 901 909.
105. Pain, A.,, B.C. Urban,, O. Kai,, C. Casals-Pascual,, J. Shafi,, K. Marsh,, and D. J. Roberts. 2001. A nonsense mutation in Cd36 gene is associated with protection from severe malaria. Lancet 357: 1502 1503.
106. Pasvol, G.,, D. J. Weatherall,, and R. J. Wilson. 1978. Cellular mechanism for the protective effect of haemoglobin S against P. falciparum malaria. Nature 274: 701 703.
107. Patel, S. S.,, C. L. King,, C. S. Mgone,, J.W. Kazura,, and P. A. Zimmerman. 2004. Glycophorin C (Gerbich antigen blood group) and band 3 polymorphisms in two malaria holoendemic regions of Papua New Guinea. Am. J. Hematol. 75: 1 5.
108. Patel, S. S.,, R. K. Mehlotra,, W. Kastens,, C. S. Mgone,, J.W. Kazura,, and P. A. Zimmerman. 2001. The association of the glycophorin C exon 3 deletion with ovalocytosis and malaria susceptibility in the Wosera, Papua New Guinea. Blood 98: 3489 3491.
109. Quaye, I. K.,, F. A. Ekuban,, B. Q. Goka,, V. Adabayeri,, J.A. Kurtzhals,, B. Gyan,, N.A. Ankrah,, L. Hviid,, and B.D. Akanmori. 2000. Haptoglobin 1-1 is associated with susceptibility to severe Plasmodium falciparum malaria. Trans. R. Soc.Trop. Med. Hyg. 94: 216 219.
110. Rest, J. R. 1982. Cerebral malaria in inbred mice. I.A new model and its pathology. Trans.R. Soc.Trop. Med. Hyg. 76: 410 415.
111. Rihet, P.,, L. Abel,, Y. Traore,, T. Traore-Leroux,, C. Aucan,, and F. Fumoux. 1998a. Human malaria: segregation analysis of blood infection levels in a suburban area and a rural area in Burkina Faso. Genet. Epidemiol. 15: 435 450.
112. Rihet, P.,, L. Flori,, F. Tall,, A. S. Traore,, and F. Fumoux. 2004. Hemoglobin C is associated with reduced Plasmodium falciparum parasitemia and low risk of mild malaria attack. Hum. Mol. Genet. 13: 1 6.
113. Rihet, P.,, Y. Traore,, L. Abel,, C. Aucan,, T. Traore- Leroux,, and F. Fumoux. 1998b. Malaria in humans: Plasmodium falciparum blood infection levels are linked to chromosome 5q31-q33. Am.J.Hum. Genet. 63: 498 505.
114. Rowe, J. A.,, J. M. Moulds,, C. I. Newbold,, and L. H. Miller. 1997. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature 388: 292 295.
115. Ruwende, C.,, S. C. Khoo,, R.W. Snow,, S.N. Yates,, D. Kwiatkowski,, S. Gupta,, P. Warn,, C. E. Allsopp,, S. C. Gilbert,, N. Peschu, et al. 1995. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 376: 246 249.
116. Sabeti, P.,, S. Usen,, S. Farhadian,, M. Jallow,, T. Doherty,, M. Newport,, M. Pinder,, R. Ward,, and D. Kwiatkowski. 2002a. CD40L association with protection from severe malaria. Genes Immun. 3: 286 291.
117. Sabeti, P. C.,, D. E. Reich,, J. M. Higgins,, H. Z. Levine,, D. J. Richter,, S. F. Schaffner,, S. B. Gabriel,, J. V. Platko,, N. J. Patterson,, G. J. McDonald,, H. C. Ackerman,, S. J. Campbell,, D. Altshuler,, R. Cooper,, D. Kwiatkowski,, R. Ward,, and E. S. Lander. 2002b. Detecting recent positive selection in the human genome from haplotype structure. Nature 419: 832 837.
118. Sayles, P.C.,, and D. L. Wassom. 1988. Immunoregulation in murine malaria. Susceptibility of inbred mice to infection with Plasmodium yoelii depends on the dynamic interplay of host and parasite genes. J. Immunol. 141: 241 248.
119. Schofield, L.,, M. C. Hewitt,, K. Evans,, M. A. Siomos,, and P. H. Seeberger. 2002. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 418: 785 789.
120. Shear, H. L.,, E. F. Roth, Jr.,, M. E. Fabry,, F. D. Costantini,, A. Pachnis,, A. Hood,, and R. L. Nagel. 1993. Transgenic mice expressing human sickle hemoglobin are partially resistant to rodent malaria. Blood 81: 222 226.
121. Sherman, I.W.,, S. Eda,, and E. Winograd. 2003. Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind. Microbes Infect. 5: 897 909.
122. Shi, Y. P.,, B. L. Nahlen,, S. Kariuki,, K. B. Urdahl,, P. D. McElroy,, J. M. Roberts,, and A. A. Lal. 2001. Fcγ receptor IIa (CD32) polymorphism is associated with protection of infants against highdensity Plasmodium falciparum infection. VII. Asembo Bay Cohort Project. J. Infect. Dis. 184: 107 111.
123. Sokhna, C. S.,, C. Rogier,, A. Dieye,, and J. F. Trape. 2000. Host factors affecting the delay of reappearance of Plasmodium falciparum after radical treatment among a semi-immune population exposed to intense perennial transmission. Am. J.Trop. Med. Hyg. 62: 266 270.
124. Stevenson, M. M.,, J. J. Lyanga,, and E. Skamene. 1982. Murine malaria: genetic control of resistance to Plasmodium chabaudi. Infect. Immun. 38: 80 88.
125. Stevenson, M. M.,, and E. M. Riley. 2004. Innate immunity to malaria. Nat. Rev. Immunol. 4: 169 180.
126. Stevenson, M. M.,, and E. Skamene. 1985. Murine malaria: resistance of AXB/BXA recombinant inbred mice to Plasmodium chabaudi. Infect.Immun. 47: 452 456.
127. Stirnadel, H. A.,, F. Al-Yaman,, B. Genton,, M. P. Alpers,, and T. A. Smith. 2000a. Assessment of different sources of variation in the antibody responses to specific malaria antigens in children in Papua New Guinea. Int. J. Epidemiol. 29: 579 586.
Stirnadel, H. A.,, H. P. Beck,, M. P. Alpers,, and T. A. Smith. 2000.b. Genetic analysis of IgG subclass responses against RESA and MSP2 of Plasmodium falciparum in adults in Papua New Guinea. Epidemiol. Infect. 124: 153 162.
Stirnadel, H. A.,, H. P. Beck,, M. P. Alpers,, and T. A. Smith. 1999.a. Heritability and segregation analysis of immune responses to specific malaria antigens in Papua New Guinea. Genet. Epidemiol. 17: 16 34.
130. Stirnadel, H. A.,, M. Stockle,, I. Felger,, T. Smith,, M. Tanner,, and H. P. Beck. 1999b. Malaria infection and morbidity in infants in relation to genetic polymorphisms in Tanzania. Trop. Med. Int. Health 4: 187 193.
131. Taylor, T. E.,, W. J. Fu,, R. A. Carr,, R. O. Whitten,, J. S. Mueller,, N. G. Fosiko,, S. Lewallen,, N. G. Liomba,, and M. E. Molyneux. 2004. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat. Med. 10: 143 145.
132. Thumwood, C. M.,, N. H. Hunt,, I. A. Clark,, and W. B. Cowden. 1988. Breakdown of the blood brain barrier in murine cerebral malaria. Parasitology 96: 579 589.
133. Tishkoff, S. A.,, R. Varkonyi,, N. Cahinhinan,, S. Abbes,, G. Argyropoulos,, G. Destro-Bisol,, A. Drousiotou,, B. Dangerfield,, G. Lefranc,, J. Loiselet,, A. Piro,, M. Stoneking,, A. Tagarelli,, G. Tagarelli,, E. H. Touma,, S. M. Williams,, and A.G. Clark. 2001. Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science 293: 455 462.
134. Tournamille, C.,, Y. Colin,, J. P. Cartron,, and C. Le Van Kim. 1995. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat. Genet. 10: 224 228.
135. Treutiger, C. J.,, A. Heddini,, V. Fernandez,, W. A. Muller,, and M. Wahlgren. 1997. PECAM- 1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes. Nat. Med. 3: 1405 1408.
136. Urban, B. C.,, D. J. Ferguson,, A. Pain,, N. Willcox,, M. Plebanski,, J. M. Austyn,, and D. J. Roberts. 1999. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells. Nature 400: 73 77.
137. Urban, B. C.,, N. Willcox,, and D. J. Roberts. 2001. A role for CD36 in the regulation of dendritic cell function. Proc. Natl. Acad. Sci. USA 98: 8750 8755.
138. Usanga, E. A.,, and L. Luzzatto. 1985. Adaptation of Plasmodium falciparum to glucose 6-phosphate dehydrogenase-deficient host red cells by production of parasite-encoded enzyme. Nature 313: 793 795.
139. Vigario, A.M.,, E. Belnoue,, A. Cumano,, M. Marussig,, F. Miltgen,, I. Landau,, D. Mazier,, I. Gresser,, and L. Renia. 2001. Inhibition of Plasmodium yoelii blood-stage malaria by interferon alpha through the inhibition of the production of its target cell, the reticulocyte. Blood 97: 3966 3971.
140. Walley, A. J.,, C. Aucan,, D. Kwiatkowski,, and A.V. Hill. 2004. Interleukin-1 gene cluster polymorphisms and susceptibility to clinical malaria in a Gambian case-control study. Eur. J. Hum. Genet. 12: 132 138.
141. Wang, H.Y.,, H. Tang,, C. K. Shen,, and C. I. Wu. 2003. Rapidly evolving genes in human. I.The glycophorins and their possible role in evading malaria parasites. Mol. Biol. Evol. 20: 1795 1804.
142. Wattavidanage, J.,, R. Carter,, K. L. Perera,, A. Munasingha,, S. Bandara,, D. McGuinness,, A. R. Wickramasinghe,, H. K. Alles,, K. N. Mendis,, and S. Premawansa. 1999. TNFα*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans. Clin. Exp. Immunol. 115: 350 355.
143. Williams, T. N.,, K. Maitland,, S. Bennett,, M. Ganczakowski,, T. E. Peto,, C. I. Newbold,, D. K. Bowden,, D. J. Weatherall,, and J. B. Clegg. 1996. High incidence of malaria in alpha-thalassaemic children. Nature 383: 522 525.
144. Williams, T. N.,, S. Wambua,, S. Uyoga,, A. Macharia,, J. K. Mwacharo,, C. R. Newton,, and K. Maitland. 2005. Both homozygous and heterozygous α +-thalassemia protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya. Blood 106: 368 371.
145. Yazdani, S. S.,, A. R. Shakri,, P. Mukherjee,, S. K. Baniwal,, and C. E. Chitnis. 2004. Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein. Vaccine 22: 3727 3737.
146. Zimmerman, P. A.,, J. Fitness,, J. M. Moulds,, D.T. McNamara,, L. J. Kasehagen,, J. A. Rowe,, and A.V. Hill. 2003. CR1 Knops blood group alleles are not associated with severe malaria in the Gambia. Genes Immun. 4: 368 373.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error